ABOUT US

No Finish Line Means No Limits

Salix Pharmaceuticals is one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases. We are focused on constantly innovating to improve patients’ lives.

We gain a deeper understanding of the GI conditions our products treat by connecting with the patients who use them and the healthcare professionals (HCPs) who prescribe them. Our therapeutic areas of expertise include management of conditions, such as type 2 diabetes, hepatic encephalopathy, irritable bowel syndrome with diarrhea, opioid-induced constipation, and ulcerative colitis.

We employ dedicated and innovative team members who are driven to problem-solve. We strive to improve upon existing treatments, uncover new breakthroughs, and deliver comprehensive practice support to arm HCPs with life-changing solutions.

The landscape of healthcare will continue to change, and new patients will continue to present with new needs. That’s why there is no finish line for our innovation and no limit to our potential.

A Letter From Leadership

See how Salix is leading our team toward innovation

Read More

A Letter From Leadership

See how Salix is leading our team toward innovation

Read More

A Long History of Discovery

Almost three decades of leading GI treatment breakthroughs

Read Our Story

Your Share of Possible

Valeant gives our shareholders an investment in endless possibilities

Stay Up to Date

Medical Conferences & Meetings

Collaborate with Salix at dozens of upcoming events in 2017

The Highest Standards

We realize that operating with transparency develops and fosters trust

Visit, Ask, Connect

Have a medical, investor, or media-related question?